Floatz logo

Therapeutic Asset Ratings

602 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
124I-cRGDY-PEG-dots
Brain Neoplasm
Memorial Sloan Kettering Cancer CenterN/AD (30)
124i-humanized 3f8
Neuroblastoma
Memorial Sloan Kettering Cancer CenterN/AD (30)
124i-humanized 3f8
Sarcoma
Memorial Sloan Kettering Cancer CenterN/AD (30)
18F-ASIS
Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer CenterD (30)
18F-ASIS
Prostate Adenocarcinoma
Memorial Sloan Kettering Cancer CenterD (30)
18F-ASIS
Prostate Neoplasm
Memorial Sloan Kettering Cancer CenterD (30)
68ga-hbed-ipsma
Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer CenterD (30)
68ga-hbed-ipsma
Metastatic Prostate Carcinoma
Memorial Sloan Kettering Cancer CenterD (30)
68ga-hbed-ipsma
Prostate Neoplasm
Memorial Sloan Kettering Cancer CenterD (30)
Apolipoprotein E
Breast Carcinoma
Memorial Sloan Kettering Cancer CenterD (30)
Etodolac
Epithelial Ovarian Cancer
Memorial Sloan Kettering Cancer CenterN/AD (30)
Etodolac
Ovarian Carcinoma
Memorial Sloan Kettering Cancer CenterN/AD (30)
Etodolac
Primary Peritoneal Carcinoma
Memorial Sloan Kettering Cancer CenterN/AD (30)
Meclofenamic Acid
Progressive Brain Metastases
Memorial Sloan Kettering Cancer CenterN/AD (30)
Meclofenamic Acid
Recurrent Brain Metastases
Memorial Sloan Kettering Cancer CenterN/AD (30)
Pyruvate
Malignant Solid Tumors
Memorial Sloan Kettering Cancer CenterN/AD (30)
124i-humanized 3f8
Melanoma
Memorial Sloan Kettering Cancer CenterN/AD (28)
Etodolac
Fallopian Tube Cancer
Memorial Sloan Kettering Cancer CenterN/AD (28)
Iodixanol
Colorectal Cancer Metastatic
Memorial Sloan Kettering Cancer CenterD (28)
Revaree Plus
Breast Carcinoma
Memorial Sloan Kettering Cancer CenterP4NR (0)
Igpro20
Common Variable Immunodeficiency
Memorial Sloan Kettering Cancer CenterP2NR (0)
BMS-986504
Gastroesophageal Adenocarcinoma
Memorial Sloan Kettering Cancer CenterP1NR (0)
Codrituzumab
Primary Extra-cranial Solid Tumor
Memorial Sloan Kettering Cancer CenterP1NR (0)
Codrituzumab
Recurrent or Refractory Glypican 3 (GPC3)
Memorial Sloan Kettering Cancer CenterP1NR (0)
Pu-H71
Active Solid Malignancy
Memorial Sloan Kettering Cancer CenterEarly P1NR (0)
Showing 576 to 600 of 602 assets
PreviousPage 24 of 25Next